CIK 0001740279 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
IN8BIO, INC.
Sign in to watch- Ticker
- INAB
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 825462585
- Phone
- (646) 600-6438
- Business address
- EMPIRE STATE BUILDING, 350 5TH AVENUE, SUITE 5330, NEW YORK, NY, 10118
- Former names
- Incysus Therapeutics, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 68 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-05-08 | Greenwood Luba Director | Grant or award · Stock Option (right to buy) | +63,150 | 63,150 | ||
| 2025-05-08 | Graff Jeremy R. Director | Grant or award · Stock Option (right to buy) | +63,150 | 63,150 | ||
| 2025-05-08 | FAIRBAIRN EMILY Director | Grant or award · Stock Option (right to buy) | +63,150 | 63,150 | ||
| 2025-05-08 | Epperly Corinne Director | Grant or award · Stock Option (right to buy) | +63,150 | 63,150 | ||
| 2025-05-08 | Brandt Peter C. Director | Grant or award · Stock Option (right to buy) | +63,150 | 63,150 | ||
| 2025-05-08 | Roemer Alan S. Director | Grant or award · Stock Option (right to buy) | +63,150 | 63,150 | ||
| 2025-05-02 | Fletcher Aaron G.L. 10% owner | Purchase · Pre-Funded Warrants | +1,148,482 | 2,431,763 | ||
| 2025-05-02 | Fletcher Aaron G.L. 10% owner | Other disposition · Series A Warrant | −574,241 | 0 | ||
| 2025-05-02 | Fletcher Aaron G.L. 10% owner | Other disposition · Series B Warrant | −574,241 | 0 | ||
| 2025-05-02 | Kreis Leslie W. 10% owner | Purchase · Pre-Funded Warrants | +1,148,482 | 2,431,763 | ||
| 2025-05-02 | Kreis Leslie W. 10% owner | Other disposition · Series A Warrant | −574,241 | 0 | ||
| 2025-05-02 | Kreis Leslie W. 10% owner | Other disposition · Series B Warrant | −574,241 | 0 | ||
| 2025-05-01 | Ho William Tai-Wei PRESIDENT AND CEO | Returned to the company · Series A Warrants (right to buy) | −81,967 | 0 | ||
| 2025-05-01 | Ho William Tai-Wei PRESIDENT AND CEO | Grant or award · Pre-Funded Warrant (right to buy) | +81,967 | $0.18 | $15K | 81,967 |
| 2025-04-30 | Rochlin Kate Chief Operating Officer | Option exercise | +12,295 | $0.18 | $2K | 55,169 |
| 2025-04-30 | Rochlin Kate Chief Operating Officer | Option exercise · Series A Warrants (right to buy) | −12,295 | 0 | ||
| 2025-04-30 | McCall Patrick CHIEF FINANCIAL OFFICER | Option exercise | +15,000 | $0.18 | $3K | 67,071 |
| 2025-04-30 | McCall Patrick CHIEF FINANCIAL OFFICER | Option exercise · Series A Warrants (right to buy) | −15,000 | 0 | ||
| 2025-04-30 | Roemer Alan S. Director | Option exercise | +102,459 | $0.18 | $19K | 387,489 |
| 2025-04-30 | Roemer Alan S. Director | Option exercise | +11,000 | $0.18 | $2K | 398,489 |
Page 2 of 9 · 179 trades